Living Longer and Healthier

through Preventative Medicine
and Biotechnology

“2060” is a Foundation whose purpose is to help Humanity Defeat Aging by 2060

THE NEXT MAJOR REVOLUTIONS FOR HUMANITY:
FIRST PREVENTATIVE MEDICINE AND ULTIMATELY EXTENDED LIFESPAN

Living 150 years or even more is no longer a pipe dream. Science and medicine have made tremendous progress in Longevity in the last decade. We are the first generation in the History of Humanity for whom extended lifespan is an ambitious yet attainable goal. However, we need to foster public & political awareness, and channel massive financial & human resources into the Longevity Field in order to discover the secrets of life within our lifetimes.

LET’S WORK TOGETHER!

Our Activity

The “2060” Foundation is active in 4 main areas. Tackled together, we will push Humanity beyond the tipping point where everyone will want to live a long and healthy life, and where R&D will be easy to fund and support.

Fundamental R&D
in Longevity

“Top Down” & “Bottom Up”
Advocacy

Federating the Longevity Ecosystem

Worldwide Network of Longevity Hubs.

About us

We are a small yet vibrant community of research scientists, venture capitalists, medical doctors and entrepreneurs who believe in radical life extension. The most important breakthroughs in Human History happened because a small group of highly determined and well organized people believed it was possible, and acted upon it. We believe in long term plans and goals. We believe in audacity, persistence and determination. We want to make Longevity one of the most important topics of our epoch (such as AI and ecology are considered today).

DEFEATING AGING BY 2060

Roughly 4 decades to change everything. We overestimate what we can do in 1 year, and we underestimate what we can do on in 10 years. There’s a lot of work to do, but there’s a realistic path to get there in time. Let’s do it!

2 MAJOR COMPLEMENTARY YET DISTINCT AREAS OF ADVOCACY AND ACTION

Lifespan and Healthspan: 2 sides of the same coin

Our Founding Team

Gabriel CIAN

Serial Tech Entrepreneur turning Biotech Entrepreneur. Graduated Ecole Polytechnique and Telecom Paristech. Sold his last startup to a big US corporation.

Max KAMRANI

Software Engineer. Expertise in AI. Graduated Ecole Centrale. Worked for 10 years for Biotech and Health Startups, mostly in the Bay Area. Avid networker, deep knowledge of the Longevity Ecosystem.

This image has an empty alt attribute; its file name is manish-chamoli.jpeg

Manish CHAMOLI, PhD

Scientist at the Buck Institute for Research on Aging, with 15 years of research experience in aging biology and early drug discovery. Specializes in the identification and characterization of novel pathways, targets, and mechanisms driving aging and age-related diseases.

Luisa GEORGIANA BACA, MD, PhD

Physician Scientist, Postdoctoral Fellow at the Laboratory of Cardiovascular Science, National Institute on Aging, NIH age-related diseases.

Paolo BINETTI, PhD

Specialist in longevity biotech, with extensive experience in dealflow management, from sourcing to due diligence and portfolio oversight at VitaDAO and Healthspan Capital. Holds a PhD in controls, robotics, and bioengineering, and multiple advanced certifications in drug discovery, bioinformatics, and venture finance.

Stephanie LINDSTROM, MS

SVP Science & Technology at SSP, Board Advisor to Startups. Core Team at Rejuvenation Technologies and Genentech. Passionate about translating innovative science technologies to address unmet medical needs and improve the human condition. Holder of multiple U.S. patents

Advisory Board

Brian Kennedy, PhD

Director, Healthy Longevity translational Research Programme and Professor Departments of Biochemistry and Physiology at National University of Singapore | Researcher | Visionary

JOIN US, WE NEED YOU TO HELP US REACH INDEFINITE LIFESPAN

Reaching Indefinite Lifespan requires massive human and financial resources (yet negligible if we look at what we want to achieve).